Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
84,120,192
-
Share change
-
+8,467,057
-
Total reported value
-
$815,961,572
-
Put/Call ratio
-
36%
-
Price per share
-
$9.70
-
Number of holders
-
135
-
Value change
-
+$78,686,366
-
Number of buys
-
75
-
Number of sells
-
57
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2021
As of 30 Jun 2021,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,120,192 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, NEA Management Company, LLC, Avoro Capital Advisors LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, Avidity Partners Management LP, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, and FRAZIER MANAGEMENT LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.